SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
TNYA

Tenaya Therapeutics, Inc. (NASDAQ:TNYA)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.29-$0.01 (-3.99%)
 
Market cap
$65.3M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 30, 2021
Market Cap$65.32M-76.7%
Revenue (ttm)$3.03M
Net Income-$101.78M-8.0%
EPS-$0.49+36.7%
Shares Out227.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,341,574
Open$0.29
Previous Close$0.30
Day's Range$0.28 - $0.32
52-Week Range$0.28 - $1.46
Beta2.88
AnalystsBuy
Price Target$2.33(+712.98%)
Earnings DateMar 10, 2027

About TNYA

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Address
171 Oyster Point Boulevard, South San Francisco, CA, 94080, US
Market Cap
65 million
Employees
70
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$2.92M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From TNYA’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-3.99%
5 Days
-19.13%
1 Month
-26.55%
6 Months
-63.72%
1 Year
-76.70%

$TNYA stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in TNYA holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by TNYA's directors and management

Net Shares Purchased by Insiders−6M−3M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

TNYA Estimated quarterly lobbying spending

Source: U.S. Senate LDA

TNYA Revenue by Segment

$3.82MTotal
Collaboration revenue$1.70M44.42%
Loss on lease termination, net$1.37M35.81%
Impairment loss$666.00K17.43%
Loss on disposal of property and equipment$89.00K2.33%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New TNYA patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to TNYA from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in TNYA

VTIVanguard Morningstar Total Stock Market ETF$1.49M
VXFVanguard Extended Market ETF$953.15K
IBBiShares Biotechnology ETF$490.55K
PRFZInvesco RAFI US 1500 Small-Mid ETF$88.48K
QQQSInvesco NASDAQ Future Gen 200 ETF$52.05K
IBBQInvesco Nasdaq Biotechnology ETF$5.35K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from TNYA’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
25
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

QQQSInvesco NASDAQ Future Gen 200 ETF0.31%
IBBiShares Biotechnology ETF0.01%
IBBQInvesco Nasdaq Biotechnology ETF0.00%
BIBProShares Ultra Nasdaq Biotechnology0.00%

Weight is the stock’s share of each fund’s holdings.